Andreas H Groll Selected Research

Andreas H Groll Research Topics

Disease

40	Infections 03/2024 - 03/2002
35	Neoplasms (Cancer) 04/2024 - 03/2006
31	Mycoses (Diseases, Fungus) 04/2024 - 03/2002
21	Invasive Fungal Infections 10/2019 - 03/2002
17	Aspergillosis 10/2023 - 01/2002
14	Neutropenia 07/2023 - 09/2007
13	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 07/2009
12	Candidiasis (Moniliasis) 08/2013 - 05/2002
11	Fever (Fevers) 12/2023 - 01/2010
11	Body Weight (Weight, Body) 03/2023 - 01/2002
9	Invasive Pulmonary Aspergillosis 01/2023 - 01/2002
9	Leukemia 01/2023 - 01/2017
7	Communicable Diseases (Infectious Diseases) 11/2023 - 03/2012
6	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2024 - 01/2004
5	Lymphoma (Lymphomas) 10/2022 - 03/2014
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 01/2020
4	Pulmonary Aspergillosis 07/2015 - 01/2002
4	Invasive Candidiasis 08/2013 - 12/2005
3	Toxoplasmosis 12/2023 - 01/2018
3	Bacterial Infections (Bacterial Infection) 12/2023 - 01/2020
3	Sepsis (Septicemia) 07/2021 - 10/2019
3	Agranulocytosis (Granulocytopenia) 01/2021 - 03/2008
3	Bone Marrow Failure Disorders 02/2017 - 07/2009
2	COVID-19 03/2024 - 01/2023
2	Cysts 12/2023 - 03/2021
2	Lymphopenia (Lymphocytopenia) 07/2023 - 08/2017
2	Febrile Neutropenia 05/2023 - 02/2017
2	Opportunistic Infections (Opportunistic Infection) 10/2022 - 03/2021
2	Clinical Deterioration 12/2021 - 07/2021
2	Papilloma (Papillomatosis) 01/2021 - 11/2014
2	Colitis 01/2021 - 01/2015
2	Recurrent respiratory papillomatosis 01/2021 - 11/2014
2	Candidemia 12/2020 - 01/2017
2	Breakthrough Infections 12/2019 - 03/2006
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 02/2014
2	Necrosis 08/2017 - 04/2017
2	Lung Injury 06/2003 - 01/2002
2	Pulmonary Infarction 06/2002 - 01/2002

Drug/Important Bio-Agent (IBA)

15	liposomal amphotericin B FDA Link 12/2020 - 06/2002
12	Antifungal AgentsIBA 04/2024 - 07/2009
11	Voriconazole (Vfend)FDA LinkGeneric 11/2023 - 03/2002
11	EchinocandinsIBA 10/2023 - 01/2002
10	posaconazole FDA Link 01/2021 - 01/2004
10	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2020 - 01/2002
9	galactomannanIBA 01/2023 - 01/2002
9	Micafungin (FK463)FDA Link 07/2015 - 06/2002
7	AntigensIBA 03/2024 - 01/2002
7	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 10/2019
7	TriazolesIBA 01/2019 - 06/2003
7	Caspofungin (Cancidas)FDA Link 04/2013 - 01/2002
5	Biomarkers (Surrogate Marker)IBA 10/2019 - 04/2013
5	Fluconazole (Zonal)FDA LinkGeneric 12/2012 - 10/2004
4	Imatinib Mesylate (Gleevec)FDA Link 10/2022 - 02/2014
4	Rituximab (Mabthera)FDA Link 10/2022 - 08/2017
4	Immunosuppressive Agents (Immunosuppressants)IBA 12/2021 - 04/2013
3	VaccinesIBA 03/2024 - 03/2021
3	letermovirIBA 01/2024 - 01/2021
3	blinatumomabIBA 10/2022 - 03/2021
3	pembrolizumabIBA 10/2022 - 03/2021
3	Inotuzumab OzogamicinIBA 10/2022 - 03/2021
3	Monoclonal AntibodiesIBA 09/2021 - 04/2017
3	SuspensionsIBA 09/2020 - 08/2002
3	isavuconazoleIBA 01/2019 - 01/2017
2	venetoclaxIBA 04/2024 - 10/2022
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2023 - 01/2004
2	tisagenlecleucelIBA 10/2022 - 03/2021
2	nilotinib FDA Link 10/2022 - 09/2021
2	Dasatinib (BMS 354825)FDA Link 10/2022 - 09/2021
2	Gemtuzumab (Mylotarg)FDA Link 10/2022 - 03/2021
2	Brentuximab VedotinIBA 10/2022 - 03/2021
2	polyglucosanIBA 12/2021 - 11/2016
2	NivolumabIBA 09/2021 - 03/2021
2	Chimeric Antigen ReceptorsIBA 09/2021 - 03/2021
2	Basiliximab FDA Link 03/2021 - 08/2017
2	IpilimumabIBA 03/2021 - 08/2017
2	Alemtuzumab (Campath)FDA Link 03/2021 - 08/2017
2	Abatacept (Orencia)FDA Link 03/2021 - 08/2017
2	Anti-Infective Agents (Microbicides)IBA 03/2021 - 02/2012
2	Bevacizumab (Avastin)FDA Link 01/2021 - 11/2014
2	Acyclovir (Aciclovir)FDA LinkGeneric 10/2019 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 08/2017 - 04/2017
2	CytokinesIBA 04/2017 - 08/2013
2	AzolesIBA 07/2015 - 03/2014
2	PolyenesIBA 12/2012 - 12/2003
2	BilirubinIBA 01/2012 - 03/2002
2	2- amino- 4- methylenecyclopentane- 1- carboxylic acidIBA 05/2005 - 10/2004
2	Isoleucine-tRNA LigaseIBA 05/2005 - 10/2004
2	ER 30346 (ravuconazole)IBA 04/2004 - 06/2003
1	midostaurinIBA 04/2024

Therapy/Procedure

48	Therapeutics 04/2024 - 01/2002
27	Hematopoietic Stem Cell Transplantation 07/2023 - 01/2004
19	Cell Transplantation 01/2024 - 03/2020
18	Drug Therapy (Chemotherapy) 01/2023 - 01/2004
11	Stem Cell Transplantation 12/2023 - 01/2008
10	Transplantation 12/2023 - 01/2004
4	Catheters 12/2020 - 05/2010
3	Chemoprevention 01/2019 - 03/2012
3	Salvage Therapy 01/2006 - 01/2004
2	Immunotherapy 04/2024 - 08/2013
2	Central Venous Catheters 01/2021 - 01/2011